Prospective, unmasked, randomized evaluation of the iStent in patients with primary open-angle glaucoma. Patients will be randomized to one of two groups: 1) iStent, or 2) medication.
Two hundred patients will be enrolled in the study at up to 21 clinical sites; follow-up is through 1 year.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
192
iStent
Combination latanoprost/timolol
SV Malayan Ophthalmological Center
Yerevan, Armenia
Allgemeines Krankenhaus Wien
Vienna, Austria
CHU de Lyon Hopital Edouard Herriot
Lyon, France
Mean intraocular pressure (IOP)
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHNO des Quinze-Vingts
Paris, France
Knapschaftskrankenhaus Bochum Langendreer
Bochum, Germany
Helios Cliniic
Erfurt, Germany
Universitatsklinkum Erlangen
Erlangen, Germany
AHEPA Hospital
Thessaloniki, Greece
Universita'degli Studi di Parma
Parma, Italy
Universita' di Torino/Dipartimento di Fisiopatologia Clinica-Clinica Oculistica
Torino, Italy
...and 6 more locations